1 mg/ml
Trade Name
PAFINUR
Oral Solution
Request Type
Registration
Drug Type
New Drug
Approval Date
SFDA Approved Use
Rupatadine Fumarate 1 mg/ml oral solution is indicated for the symptomatic treatment of:
-Allergic rhinitis (including persistent allergic rhinitis) in children aged 2 to 11 years.
-Urticaria in children aged 2 to 11 years.
-Allergic rhinitis (including persistent allergic rhinitis) in children aged 2 to 11 years.
-Urticaria in children aged 2 to 11 years.